Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Nash

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Allergy and Asthma Proceedings|September 17, 2025
Baseline disease characteristics among patients with chronic rhinosinusitis with nasal polyps in AROMA: A global registry studyAnju T Peters, Rachna Shah, Enrico Heffler, et al.
Frontiers in Immunology|May 1, 2024
The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polypsClaus Bachert, Alexandra Hicks, Simon Gane, et al.
Advances in Therapy|December 24, 2025
Correction to: Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 StudiesMartin Desrosiers, Scott Nash, Andrew Lane, et al.
Advances in Therapy|September 27, 2025
Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 StudiesMartin Desrosiers, Scott Nash, Andrew Lane, et al.
Allergy and Asthma Proceedings|July 22, 2023
Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitisAnju T Peters, Martin Wagenmann, Jonathan A Bernstein, et al.
Journal of Asthma and Allergy|April 25, 2023
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma CharacteristicsWilliam Walter Busse, Ian Douglas Pavord, Shahid Siddiqui, et al.
Clinical & Translational Immunology|June 10, 2024
Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS-52 trialWytske J Fokkens, Claus Bachert, Claire Hopkins, et al.
Journal of Comparative Effectiveness Research|February 11, 2026
Treatment burden and healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps who did or did not undergo functional endoscopic sinus surgery: a US real-world retrospective cohort studyDanielle L Isaman, Mark Corbett, Stella E Lee, et al.
Advances in Therapy|October 9, 2024
Reduced Sense of Smell in Patients with Severe Chronic Rhinosinusitis and its Implications for Diagnosis and Management: A Narrative ReviewZachary M Soler, Scott Nash, Andrew P Lane, et al.
Journal of Asthma and Allergy|January 22, 2024
Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting AsthmaMark Gurnell, Amr Radwan, Claus Bachert, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Allergy and Asthma Proceedings|September 17, 2025
Baseline disease characteristics among patients with chronic rhinosinusitis with nasal polyps in AROMA: A global registry studyAnju T Peters, Rachna Shah, Enrico Heffler, et al.
Frontiers in Immunology|May 1, 2024
The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polypsClaus Bachert, Alexandra Hicks, Simon Gane, et al.
Advances in Therapy|December 24, 2025
Correction to: Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 StudiesMartin Desrosiers, Scott Nash, Andrew Lane, et al.
Advances in Therapy|September 27, 2025
Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 StudiesMartin Desrosiers, Scott Nash, Andrew Lane, et al.
Allergy and Asthma Proceedings|July 22, 2023
Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitisAnju T Peters, Martin Wagenmann, Jonathan A Bernstein, et al.
Journal of Asthma and Allergy|April 25, 2023
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma CharacteristicsWilliam Walter Busse, Ian Douglas Pavord, Shahid Siddiqui, et al.
Clinical & Translational Immunology|June 10, 2024
Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS-52 trialWytske J Fokkens, Claus Bachert, Claire Hopkins, et al.
Journal of Comparative Effectiveness Research|February 11, 2026
Treatment burden and healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps who did or did not undergo functional endoscopic sinus surgery: a US real-world retrospective cohort studyDanielle L Isaman, Mark Corbett, Stella E Lee, et al.
Advances in Therapy|October 9, 2024
Reduced Sense of Smell in Patients with Severe Chronic Rhinosinusitis and its Implications for Diagnosis and Management: A Narrative ReviewZachary M Soler, Scott Nash, Andrew P Lane, et al.
Journal of Asthma and Allergy|January 22, 2024
Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting AsthmaMark Gurnell, Amr Radwan, Claus Bachert, et al.
Pageof 5